Update Schmerztherapie

Zusammenfassung

In dieser Übersicht werden in einem Teil die Prinzipien der Schmerztherapie sowie die wichtigsten nicht medikamentösen und medikamentösen Therapieverfahren dargestellt. Dies erfolgt unabhängig von der Ätiologie der Schmerzen. In einem speziellen Teil werden die Neuerungen in der Therapie neuropathischer Schmerzen und der Kopfschmerzen sowie der Therapie mit Opioidanalgetika abgehandelt. Neue Substanzen und neue Applikationsverfahren bei den medikamentösen Therapie werden vorgestellt.

Summary

In this review, the general principles of pain therapy and the most important common pharmacological and non-pharmacological procedures for pain treatment are described. These procedures are applied independently from the pain origin. In a specific part of the review, recent advancements in the treatment of headaches and neuropathic pain and in pain treatment with opioids are described. New substances and new applications of drugs are introduced.

Schlüsselwörter

Schmerztherapie - Opioide - Kopfschmerzen - neuropathische Schmerzen - interventionelle Verfahren

Keywords

Pain therapy - opioids - headache - neuropathic pain - interventional treatment

• Literatur

• 1 Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth 2011; 107: 490-502.
• 2 Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF. PREEMPT 1 Chronic Migraine Study Group.. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010; 30: 793-803.
• 3 Buynak R, Shapiro DY, Okamoto A, Van Hove I, Rauschkolb C, Steup A, Lange B, Lange C, Etropolski M. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opin Pharmacother 2010; 11: 1787-804.
• 4 Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manage 2009; 38: 683-90.
• 5 Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF. PREEMPT 2 Chronic Migraine Study Group.. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30: 804-14.
• 6 Frampton JE. Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain. Drugs 2010; 70: 1719-43.
• 7 Geber C, Klein T, Azad S, Birklein F, Gierthmühlen J, Huge V, Lauchart M, Nitzsche D, Stengel M, Valet M, Baron R, Maier C, Tölle T, Treede RD. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Pain 2011; 152: 548-56.
• 8 Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374: 1252-61.
• 9 Jenkins B, Tepper SJ. Neurostimulation for primary headache disorders: part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation. Headache 2011; 51: 1408-18.
• 10 Reinecke H, Sorgatz H. Deutsche Gesellschaft zum Studium des Schmerzes (DGSS).. S-3- Leitlinie LONTS Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen. Schmerz 2009; 23: 440-7.